Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jun;27(2):121-9.
doi: 10.1007/s11011-012-9302-1. Epub 2012 Apr 14.

Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms

Derbis Campos  1 , Madelyn Monaga
Affiliations
Review

Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms

Derbis Campos et al. Metab Brain Dis. 2012 Jun.

Abstract

Mucopolysaccharidosis type I is one of the most frequent lysosomal storage diseases. It has a high morbidity and mortality, causing in many cases severe neurological and somatic damage in the first years of life. Although the clinical phenotypes have been described for decades, and the enzymatic deficiency and many of the mutations that cause this disease are well known, the underlying pathophysiological mechanisms that lead to its development are not completely understood. In this review we describe and discuss the different pathogenic mechanisms currently proposed for this disease regarding its neurological damage. Deficiency in the lysosomal degradation of heparan sulfate and dermatan sulfate, as well as its primary accumulation, may disrupt a variety of physiological and biochemical processes: the intracellular and extracellular homeostasis of these macromolecules, the pathways related to gangliosides metabolism, mechanisms related to the activation of inflammation, receptor-mediated signaling, oxidative stress and permeability of the lysosomal membrane, as well as alterations in intracellular ionic homeostasis and the endosomal pathway. Many of the pathogenic mechanisms proposed for mucopolysaccharidosis type I are also present in other lysosomal storage diseases with neurological implications. Results from the use of methods that allow the analysis of multiple genes and proteins, in both patients and animal models, will shed light on the role of each of these mechanisms and their combination in the development of different phenotypes due to the same deficiency.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hum Pathol. 1994 Mar;25(3):276-86 - PubMed
    1. Adv Exp Med Biol. 2002;513:335-51 - PubMed
    1. Mol Genet Metab. 2001 Mar;72(3):239-47 - PubMed
    1. J Biol Chem. 2003 Oct 31;278(44):43229-35 - PubMed
    1. J Neuropathol Exp Neurol. 2007 Aug;66(8):760-9 - PubMed

MeSH terms

LinkOut - more resources